Correlation of West Nile Virus Incidence in Donated Blood with West Nile Neuroinvasive Disease Rates, United States, 2010–2012
Edouard Betsem, Zhanna Kaidarova, Susan L. Stramer, Beth Shaz, Merlyn Sayers, German LeParc, Brian S. Custer, Michael P. Busch
, and Edward L. Murphy
Author affiliations: University of Yaounde 1 Faculty of Medicine and Biomedical Sciences, Yaounde, Cameroon (E. Betsem); Agence de Médecine Préventive, Bobo-Dioulasso, Burkina Faso (E. Betsem); Blood Systems Research Institute, San Francisco, California, USA (E. Betsem, Z. Kaidarova, B. Custer, M.P. Busch, E.L. Murphy); American Red Cross, Gaithersburg, Maryland, USA (S.L. Stramer); New York Blood Center, New York, New York, USA (B. Shaz); Carter BloodCare, Bedford, Texas, USA (M. Sayers); University of Texas Southwestern Medical Center, Dallas, Texas, USA (M. Sayers); OneBlood, St. Petersburg, Florida, USA (G. LeParc); University of California, San Francisco (B. Custer, M.P. Busch, E.L. Murphy)
Main Article
Figure 3
Figure 3. Incidence of West Nile virus (WNV) infection cases and neuroinvasive disease (NID) cases by state, United States, 2010–2012. Dots indicate attack rates for NID cases reported to the Centers for Disease Control and Prevention in 2010 (A), 2011 (B), and 2012 (C).
Main Article
Page created: January 17, 2017
Page updated: January 17, 2017
Page reviewed: January 17, 2017
The conclusions, findings, and opinions expressed by authors contributing to this journal do not necessarily reflect the official position of the U.S. Department of Health and Human Services, the Public Health Service, the Centers for Disease Control and Prevention, or the authors' affiliated institutions. Use of trade names is for identification only and does not imply endorsement by any of the groups named above.